Daily17h
Submit active controlled CT design for moderate to very severe COPD patients: CDSCO Panel tells Zydus Healthcare on Revefenacin inhalation
This came after Zydus Healthcare presented the proposal for grant of permission for manufacturing and marketing of the drug ...
Daily19h
Zydus barred from selling cancer drug Sigrima as Delhi HC restores injunction in favour of Roche
Upholding the patent rights of Swiss pharmaceutical giant F-Hoffmann-La Roche AG, the Delhi High Court has once again ...
Panel recommends health supplements claiming to cure, mitigate disease be classified as drugs
An inter-ministerial committee has recommended classifying health supplements that claim to cure diseases as drugs. This move would subject them to stricter scrutiny by the CDSCO and price regulations ...